AstraZeneca: Jonathan Van Tam insists vaccine is 'beneficial'
When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations for other related newsletters or services we offer.Our Privacy Notice explains more about how we use your data, and your rights.You can unsubscribe at any time.
Jonathan Van-Tam joined Health Secretary Matt Hancock at a No10 presser and was visibly frustrated over Europe’s pausing of the AstraZeneca vaccine over fears it causes fatal bloodclots and other harmful side effects. Professor Van-Tam bluntly explained that all drugs have side effects and that the coronavirus vaccine’s blood clot risk is not anomalous and is entirely expected. To prove his point, the government advisor brought out a datasheet for paracetamol and listed off side effects like “difficulty breathing” to illustrate that drugs need to be weighed up versus the likelihood and severity of their side effects.
Professor Van-Tam slammed the vaccine pausing in Europe and across the world and said: “Vaccines don’t save lives if they’re in fridges.
“They only save lives if they’re in arms, and that’s a really important fact that all medicines have side effects and all medicines have benefits and that’s the whole point.
“You have to look at both sides and say, how big are the benefits in relation to the risks.
“So even something really simple like paracetamol, and here is a datasheet from box of paracetamol, the rare side effects are allergic reactions such as skin rash mouth sores, fever, difficulty breathing, more prone to bleeding bruising fever infections, nausea, sudden weight loss, loss of appetite, jaundice yellowing of the eyes and skin.
“Those are documented rare side effects of paracetamol, but we all understand the benefits of them.
“And this is no different, there is no proven association with the blood clots and we have very clear evidence that these vaccines are beneficial and save lives from what is a potentially lethal disease.
MORE TO FOLLOW
Source: Read Full Article